Literature DB >> 952899

DNA-binding proteins in Yoshida ascites tumor fluid.

J Kroll, J K Larsen, H Loft, M Ezban, K Wallevik, M Faber.   

Abstract

DNA-binding proteins were isolated from Yoshida ascites tumor fluid by chromatography on DNA-cellulose. This fraction represents 1-2% of the total ascites protein. Most of the DNA-binding proteins will bind to phosphocellulose as well. The proteins migrate by agarose gel electrophoresis at pH 8.6 as alpha and beta globulins. Quantitative immunoelectrophoresis revealed the presence of 12-18 proteins. SDS-polyacrylamide electrophoresis indicated molecular weights ranging from 3-10(4) to 10(6). Seven of the proteins were identified by specific immunoprecipitation as beta1-Eglobulin, beta2-glycoprotein I, fibrinogen split product E (fibrinogen E), coagulation factor XIII (factor XIII), alpha2-macroglobulin, IgG and IgM. Alpha1-antichymotrypsin might also be represented. In nuclear extracts of the tumor cells only factor XIII was present. With the exception of fibrinogen E and P5 all recognized DNA-binding proteins are present in normal rat plasma. With increasing tumor age the concentration of fibrinogen E, factor XIII, P5 and IgM increased both in ascites fluid and in plasma, while the concentration of other DNA-binding-proteins decreased or remained constant. Evidence is presented that the DNA- and phosphocellulose binding ascites protein fraction inhibit tumor cell growth. No inhibition was induced by corresponding protein fractions isolated from normal rat plasma.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 952899     DOI: 10.1016/0005-2795(76)90239-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  The interaction of beta(2)-glycoprotein I domain V with chaperonin GroEL: the similarity with the domain V and membrane interaction.

Authors:  Masayo Gozu; Masaru Hoshino; Takashi Higurashi; Hisao Kato; Yuji Goto
Journal:  Protein Sci       Date:  2002-12       Impact factor: 6.725

2.  Characterization of binding of human beta 2-glycoprotein I to cardiolipin.

Authors:  Z Kertesz; B B Yu; A Steinkasserer; H Haupt; A Benham; R B Sim
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

3.  Amino acid sequence of the UP1 calf thymus helix-destabilizing protein and its homology to an analogous protein from mouse myeloma.

Authors:  K R Williams; K L Stone; M B LoPresti; B M Merrill; S R Planck
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

4.  Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H).

Authors:  H P McNeil; R J Simpson; C N Chesterman; S A Krilis
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

5.  Complete nucleotide and deduced amino acid sequence of human beta 2-glycoprotein I.

Authors:  A Steinkasserer; C Estaller; E H Weiss; R B Sim; A J Day
Journal:  Biochem J       Date:  1991-07-15       Impact factor: 3.857

6.  The insertion of human apolipoprotein H into phospholipid membranes: a monolayer study.

Authors:  S X Wang; G P Cai; S F Sui
Journal:  Biochem J       Date:  1998-10-15       Impact factor: 3.857

7.  Amino acid sequence of the region of beta 2-glycoprotein 1 (gp1) which mediates binding of autoantibodies to the cardiolipin-gp1 complex in humans.

Authors:  S A Lauer; U Hempel; A Gries; K H Frank
Journal:  Immunology       Date:  1993-09       Impact factor: 7.397

Review 8.  Human plasma protein N-glycosylation.

Authors:  Florent Clerc; Karli R Reiding; Bas C Jansen; Guinevere S M Kammeijer; Albert Bondt; Manfred Wuhrer
Journal:  Glycoconj J       Date:  2015-11-10       Impact factor: 2.916

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.